Insights On Trial Design

  1. Antibody-Drug Conjugates: 'Magic Bullets' Become Reality 2/19/2025

    Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.

  2. Accelerate Your Oncology Breakthroughs 4/16/2025

    Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.

  3. Understanding Digital Patient Recruitment 9/22/2025

    Explore the transformative shift towards digital patient recruitment in clinical trials and the persistent challenges of traditional methods that often lead to significant enrollment failures.

  4. How Home Trial Visits Support Sites And Patients 3/20/2025

    By reaching into the heart of communities, Home Trial Support plays an invaluable role in driving the development of lifesaving, representative, medicines and therapies.

  5. Beyond The Benchmark: Innovative Trial Designs Transform Research 1/15/2026

    Adaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.

  6. Ocular Endpoint Protection In A Capital-Constrained Market 9/3/2025

    Ocular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.

  7. Travel And Payment Services: A Patient's Journey 12/5/2025

    Streamline patient travel and payments in your clinical trials by implementing centralized, high-quality concierge services that reduce burdens, improve satisfaction, and boost study performance.

  8. The True ROI Of Decentralized Clinical Trials 11/13/2025

    Gain a greater understanding of how the right DCT solution, or combination of solutions, coupled with clear metrics and expert guidance on execution, can demonstrate tangible, quantitative ROI in clinical trials.

  9. Gene, Cell, And RNA Therapy Landscape Continues To Thrive 3/21/2025

    The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.

  10. Reduction Of Screen Failures In A Biomarker 2/24/2026

    Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.